ArticleCancer control : journal of the Moffitt Cancer Center

Epidermal growth factor receptor-Mutated Non-small-cell Lung Cancer with Intracranial Progressions and Stable Extracranial Diseases Benefit from Osimertinib Regardless of T790M Mutational Status.

Jun Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.